Tranexamic acid for the prevention and management of orthopedic surgical hemorrhage: current evidence

Journal of Blood Medicine
Christopher KimJ Roderick Davey

Abstract

Total joint arthroplasty can be associated with major blood loss and require subsequent blood transfusions for postoperative anemia. Measures to effectively and safely decrease blood loss and reduce the need for blood transfusions would help improve patient safety and lower health care costs. A possible pharmacological option to reduce surgical blood loss in total joint arthroplasty is the use of tranexamic acid. Abundant literature has shown that intravenous and/or topical administration of tranexamic acid is effective in reducing blood loss and blood transfusions, with no increased risk of venous thromboembolic events or other complications.

Methods Mentioned

BETA
total hip arthroplasty

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Related Papers

Archives of Bone and Joint Surgery
Mohammad R Rasouli, Javad Parvizi
Revista española de cirugía ortopédica y traumatología
X Aguilera-RoigM J Martínez-Zapata
© 2021 Meta ULC. All rights reserved